Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fusion proteins composed of an interleukin-2 mutein and type I interferon

Fusion proteins composed of an interleukin-2 mutein and type I interferon

US Patent 11926654 · Granted Mar 12, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants i2025
Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants i2025
Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants i2023
Nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants i2023
Ganglioside GM3-containing nanoparticles as immunomodulators2023
Ganglioside GM3-containing nanoparticles as immunomodulators2023
Ganglioside GM3-containing nanoparticles as immunomodulators2023
Antibodies with increased affinity for the epidermal growth factor receptor and 2023
Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 2017
TGFβ-derived polypeptides and uses thereof2017
IL-2 derivative polypeptides2015
Immunomodulatory interleukin-2 polypeptides and methods of treating melanoma2014